{"DataElement":{"publicId":"6035047","version":"1","preferredName":"Prostate Cancer Aversion Treatment Type","preferredDefinition":"Text term for the kind of treatment an individual has an aversion to for prostate cancer.","longName":"PCA_AVRSN_TX_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6034892","version":"1","preferredName":"Prostate Carcinoma Aversion Therapeutic Procedure","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002_A strong dislike or disinclination._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"2744055v1.0:6035048v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2744055","version":"1","preferredName":"Prostate Carcinoma","preferredDefinition":"Prostate carcinoma is one of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002","longName":"C4863","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B8AEEC8-FDF2-03F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-23","modifiedBy":"ONEDATA","dateModified":"2008-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6035048","version":"1","preferredName":"Aversion Therapeutic Procedure","preferredDefinition":"A strong dislike or disinclination.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"C142158:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aversion","conceptCode":"C142158","definition":"A strong dislike or disinclination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3607BC-FE5E-3C03-E053-F662850A6B93","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"ONEDATA","dateModified":"2017-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F26627D-BD7C-0606-E053-F662850AC34B","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-29","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6032939","version":"1","preferredName":"Prostate Cancer Therapy Code","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection.","longName":"PCA_THER_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F0DD364-7360-29AC-E053-F662850A5B6E","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"ONEDATA","dateModified":"2017-11-28","deletedIndicator":"No"},{"value":"CHT","valueDescription":"Chemotherapy Endocrine Therapy","ValueMeaning":{"publicId":"4722992","version":"1","preferredName":"Chemotherapy Endocrine Therapy","longName":"4722992","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.: Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FC23548-92F0-2F46-E050-BB89AD4307CE","latestVersionIndicator":"Yes","beginDate":"2015-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F0DD364-7376-29AC-E053-F662850A5B6E","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"ONEDATA","dateModified":"2017-11-28","deletedIndicator":"No"},{"value":"FLA","valueDescription":"Focal Laser Ablation","ValueMeaning":{"publicId":"6032940","version":"1","preferredName":"Focal Laser Ablation","longName":"6032940","preferredDefinition":"In terms of cancer, limited to a specific area.: Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by light amplification by stimulated emission of radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Focal","conceptCode":"C28224","definition":"Limited to a specific area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laser Ablation","conceptCode":"C111241","definition":"Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by light amplification by stimulated emission of radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0DD364-7383-29AC-E053-F662850A5B6E","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F0DD364-739C-29AC-E053-F662850A5B6E","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"ONEDATA","dateModified":"2017-11-28","deletedIndicator":"No"},{"value":"RT","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"2567129","version":"1","preferredName":"Radiation Therapy","longName":"2567129","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D346-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F0DD364-73B0-29AC-E053-F662850A5B6E","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"ONEDATA","dateModified":"2017-11-28","deletedIndicator":"No"},{"value":"RP","valueDescription":"Radical prostatectomy","ValueMeaning":{"publicId":"2571933","version":"1","preferredName":"Radical prostatectomy","longName":"2571933","preferredDefinition":"Surgery to remove the entire prostate. The two types of radical prostatectomy are retropubic prostatectomy and perineal prostatectomy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radical Prostatectomy","conceptCode":"C15399","definition":"The surgical removal of all of the prostate as well as some surrounding tissue, including lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E60A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-16","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F0DD364-73C4-29AC-E053-F662850A5B6E","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"ONEDATA","dateModified":"2017-11-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0DD364-734A-29AC-E053-F662850A5B6E","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Treatment aversion","type":"Preferred Question Text","description":"Treatment aversion","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F33EFA9-B3C4-7201-E053-F662850A8D50","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}